Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.
Also called NCT01331902
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT01331902
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01331902. Randomized; single masking; primary purpose diagnostic. Start 2011-03 (registry gives no type); primary completion 2011-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR) Measurement
- Condition
- Coronary Artery Disease
- Condition
- Myocardial Ischemia
- Intervention (Other)
- Maximal Hyperemia with Adenosine Followed by Nicorandil
- Intervention (Other)
- Maximal Hyperemia with Nicorandil Followed by Adenosine
- Lead sponsor
- Seoul National University Hospital
- Collaborator
- Seoul National University Boramae Hospital
- Collaborator
- Inje University Ilsan Paik Hospital
- Collaborator
- Keimyung University Dongsan Medical Center
Record details
- Record id
cardio:ct-nct01331902- Content hash
0825b1c16ffe2b3cfe0f51ac78d4cd0c1db187fdfb6003a817d2dec9802de263